Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sangxingzhike is a traditional Chinese medicine formulation, most commonly available as "Sangxingzhike Granules." It is used for the treatment of cough, particularly after pulmonary infection caused by dryness pathogens. The formula typically contains a combination of herbal ingredients such as mulberry leaf (Sangye), apricot kernel (Xingren), and other botanicals known in Chinese medicine to moisten the lungs and relieve cough. Its mechanism of action is based on traditional principles—moistening lung dryness, clearing heat, and stopping cough—rather than targeting specific molecular pathways. Clinical studies are ongoing to evaluate its efficacy in post-infectious cough[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sangxingzhike.